Prevalence of metabolic syndrome in Iran
A meta-analysis
Keywords:
Prevalence, Dysmetabolic syndrome, Components, Population groups, Meta-analysis, IranAbstract
Background: Metabolic syndrome) MetS( is a complex risk factor which increases the risk of cardiovascular diseases and type 2 diabetes. There are many studies with various populations and results about the prevalence of MetS in Iran; in order to authenticate these studies and have an overall estimation of its prevalence in Iran, performing a meta-analysis seems to be necessary.
Objective: This study aimed to investigate the prevalence of MetS and its components in Iran via meta-analysis method.
Methods: All associated published papers in national and international journals of PubMed, Scopus, Web of Science, Magiran, Iranmedex, Science Direct, Medlib, and SID databases were searched from January, 2000 to October, 2016. All types of studies, including local and national surveys that reported the prevalence of MetS among healthy populations in Iran were reviewed. The effects of age, sample size and publication date as possible sources of heterogeneity among the study findings was examined by meta-regression. P-values less than 0.05 were considered as significant in heterogeneity tests. All analysis was done by R Ver. 3.2.1 and STATA (version 10).
Results: Seventy eligible studies were selected for meta-analysis. The overall estimation of MetS prevalence was 25% (95% CI: 22-29%) based on the Adult Treatment Panel III (ATP III) criteria, 30% (95% CI: 25-36%) according to the International Diabetes Federation (IDF), and 39% (95% CI: 26-52%) based on the Joint Interim Societies (JIS) criteria. The prevalence of MetS was lower in men than in women (26.9% versus 35.7%). The prevalence of various MetS components including High TG (triglyceride), Low HDL-C, High BP and High FBS (fasting blood sugar) was 43%, 54%, 38% and 22% among the adult population.
Conclusion: Findings from the present meta-analyses study displayed a high prevalence of metabolic syndrome in Iran, especially in women, which increases with age in both sexes. It alerts health care providers and policy makers to find solutions in order to take action to reduce MetS risk in society.
References
Mehrdad SM, Hosseinpanah F, Azizi F. Metabolic syndrome prevalence in 3-9 years old children: Tehran
Glucose and Lipid Study. Research in Medicine. 2006; 30(Suppl 4): 337-46.
Ghergherehchi R, Razaghi Azar M. Metabolic syndrome prevalence in obese children and adolescents.
Medical Journal of Tabriz University of Medical Sciences. 2010; 32(Suppl 3): 57-61.
Sadr Bafghi SM, Salari M, Rafiee M, Namayandeh SM, Abdoli AM, Karimi M, et al. Prevalence of
metabolic syndrome and its risk factors in an urban population: Yazd Healthy Heart Project. Journal of
Tehran University of Medical Sciences. 2006; 64(Suppl 10): 90-6.
Fakhrzadeh H, Ebrahimpoor P, Noori M, Poor Ebrahim R, Heshmat R, Shooshtarizadeh P, et al. Prevalence
of metabolic syndrome and its risk factors among population under supervision of Population Research
Center of Tehran University Of Medical Sciences. Iran Diabetes and Lipid Journal. 2006; 3(Suppl 1): 71-80.
Amirkalali B, Fakhrzadeh H, Sharifi F, Kelishadi R, Zamani F, Asayesh H, et al. Prevalence of Metabolic
Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis.
Iran Red Crescent Med J. 2015; 17(Suppl 12): e24723. doi: 10.5812/ircmj.24723. PMID: 26756015.
Kaykhaei MA, Hashemi M, Narouie B, Shikhzadeh A, Jahantigh M, Shirzaei E, et al. Prevalence of
Metabolic Syndrome in Adult Population from Zahedan, Southeast Iran. Iranian J Publ Health. 2012; 41(2):
-6. PMID: 23113137, PMCID: PMC3481671.
Jover A, Corbella E, Muñoz A, Millán J, Pintó X, Mangas A, et al. Prevalence of metabolic syndrome and
its components in patients with acute coronary syndrome. Rev Esp Cardiol. 2011; 64(7): 579–86. doi:
1016/j.recesp.2011.03.010. PMID: 21640461.
Shin JA, Lee JH, Lim SY, Ha HS, Kwon HS, Park YM, et al. Metabolic syndrome as a predictor of type 2
diabetes, and its clinical interpretations and usefulness. J Diabetes Investig. 2013; 4(4): 334–43. doi:
1111/jdi.12075. PMID: 24843675.
Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and
without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland
Coronary Prevention Study. Circulation. 2003; 108: 414-9. doi: 10.1161/01.CIR.0000080897.52664.94.
PMID: 12860911.
Jalali R, Vashaghani M, Dabaghmanesh MH, Ranjbar Omrani GHH. Metabolic syndrome prevalence in
adults of Akbar Abad Kovar, Fars Province, in 2008. Iranian Endocrinology and Metabolism Journal. 2009;
(Suppl 4): 405-14.
Santos AC, Ebrahim S, Barros H. Alcohol intake, smoking, sleeping hours, physical activity and the
metabolic syndrome. Prev Med. 2007; 44(4): 328–34. doi:10.1016/j.ypmed.2006.11.016. PMID: 17239432.
Wilsgaard T, Jacobsen BK. Lifestyle factors and incident metabolic syndrome: the Tromsø Study 1979–
Diabetes Res Clin Pract. 2007; 78(2): 217–24. doi: 10.1016/j.diabres.2007.03.006. PMID: 17448561.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the
third National Health and Nutrition Examination Survey. JAMA. 2002; 287(3): 356–9. doi:
1001/jama.287.3.356. PMID: 11790215.
Bender R, Jockel KH, Richter B, Spraul M, Berger M. Body weight, blood pressure, and mortality in a
cohort of obese patients. Am J Epidemiol. 2002; 156(3): 239–45. doi: 10.1093/aje/kwf015. PMID:
Kazemi S, Koosha A, Sharifi F, Moosavi-Nasab SND, Mellati AA: Metabolic syndrome prevalence in 17- 21 years old population of Zanjan: a new definition for waist circumference in Iranians in comparison with
ATPIII and World Diabetes Association. Iran Diabetes and Lipid Journal. 2008; 7(Suppl 4): 393-8.
Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population:
Tehran lipid and glucose study. Diabetes Res Clin Pract. 2003; 61(1): 29–37. doi: 10.1016/S0168- 8227(03)00066-4.
Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the
prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East:
the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32(6):
–7. doi: 10.2337/dc08-1800. PMID: 19279302, PMCID: PMC2681035.
Noori N, Mirmiran P, Asgari S, Azizi F. Calcium and vitamin D intake and metabolic syndrome prevalence
in Tehranian adults: Tehran Glucose and Lipid Study. Iranian Endocrinology and Metabolism Journal.
; 9(Suppl 1): 191-200.
Pyorala K. Assessment of coronary heart disease risk in populations with different levels of risk. Eur Heart
J. 2000; 21(5): 348–50. doi: 10.1053/euhj.1999.1927. PMID: 10666347.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening
the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting
observational studies. Gac Sanit. 2008; 22(2): 144– 50. doi: 10.1157/13119325. PMID: 18420014.
Ebrahimpoor P, Fakhrzadeh H, Rasoolpoor E, Hamidi A, Heshamat R, Noori M, et al. Metabolic syndrome
and its association with insulin level in obese children of primary schools of Tehran. Journal of Iran
University of Medical Sciences. 2006; 13(Suppl 51): 7-15.
Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F. High prevalence of the metabolic
syndrome in Iranian adolescents. Obesity 2006; 14(Suppl 3): 377–82. doi: 10.1038/oby.2006.50. PMID:
Sadeghi M, Roohafza HR, Shirani Sh, Baghaee AM, Golshadi I, Aghdak P. Assessment and relationship
between hematologic and metabolic syndrome parameters in Iranian population: Isfahan Healthy Heart
Study. Journal of Rafsanjan University of Medical Sciences. 2006; 5(Suppl 2): 57-61.
Malek M, Hadaegh F, Harati H, Azizi F. Predict cardiovascular events in people over 40 years of age with
metabolic syndrome according to ATP III and IDF definitions (Tehran Lipid and Glucose Study). Journal
of Endocrinology and Metabolism. 2006; 8(3): 249-57.
Gharipour M, Baghei A, Boshtam M, Rabiei K. Prevalence of metabolic syndrome among the adults of
central of areas of Iran (as part of Isfahan Healthy Heart Study). Journal of Birjand University of Medical
Sciences. 2006; 13(3): 56- 63.
Zabetian A, Hadaegh F, Tohidi M, Sheikholeslami F, Azizi F. Metabolic syndrome prevalence in middle- age population based on WHO, IDF, and ATPIII criteria and its relationship with coronary heart diseases.
Iran Diabetes and Lipid Journal. 2007; 7(Suppl 1): 91-101.
Nabipoor I, Amiri M, Imami SR, Jafari SM, Shafeiae E, Nosrati A, et al. The metabolic syndrome and
nonfatal ischemic heart disease; a population-based study. International Journal of Cardiology 2007; 118:
–53. doi: 10.1016/j.ijcard.2006.06.017. PMID: 16875744.
Salem Z, Vazirinezhad R. Prevalence of metabolic syndrome among 18 year old girls in Rafsanjan, 2007.
Iran Diabetes and Lipid Journal. 2008; 7(2): 205-13.
Hadegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F. The metabolic syndrome and incident diabetes:
Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes
Research and Clinical Practice. 2008; 80: 328-34. doi: 10.1016/j.diabres.2008.01.003. PMID: 18282630.
Kelishadi R, Gouya MM, Adeli KH, Ardalan G, Gheiratmand R, Majdzadeh R, et al. Factors associated
with the metabolic syndrome in a national sample of youths: CASPIAN Study. Nutrition, Metabolism &
Cardiovascular Diseases. 2008; 18: 461-70. doi: 10.1016/j.numecd.2007.02.014. PMID: 17935959.
Sarrafzadegan N, Kelishadi R, Baghaei A, Hussein Sadri G, Malekafzali H, Mohammadifard N, et al.
Metabolic syndrome: an emerging public health problem in Iranian women: Isfahan Healthy Heart
Program. Int J Cardiol. 2008; 131(1): 90–6. doi: 10.1016/j.ijcard.2007.10.049. PMID: 18190978.
Mirhosseini NZ, Noor- Aini MY, Shahar S, Parizadeh SMR, Mobarhen MG, Shakery MT. Prevalence of
the metabolic syndrome and its influencing factors among adolescent girls in Mashhad, Iran. Asia Pac J
Clin Nutr. 2009; 18(Suppl 1): 131-6. PMID: 19329406.
Delavar MA, Lye MS, Khor GL, Hanachi P, Hassan ST. Prevalence of metabolic syndrome among middle
aged women in Babol, Iran. Southeast Asian J Trop Med Public Health. 2009; 40(3): 612–28. PMID:
Barahimi H, Rajaie F, Esmaielian R. Prevalence of metabolic syndrome in women of reproductive age in
Shahreza, 2007. Iran Diabetes and Lipid Journal. 2009; 8(2): 177-84.
Saberi HR, Parastooie K, Maroji SA. Metabolic syndrome in bus and truck drivers in Kashan. Iranian
South Medical Journal. 2009; 12(2): 126-32.
Sharifi F, Mousavinasab SN, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult
urban population of the west of Iran. Exp Diabetes Res. 2009; 2009: 136501. doi: 10.1155/2009/136501.
PMID: 19893638.
Chiti H, Hosseinpanah F, Mehrabi Y, Azizi F. The Prevalence of Metabolic Syndrome in Adolescents with
Varying Degrees of Body Weight: Tehran Lipid and Glucose Study (TLGS). Iranian Journal of
Endocrinology & Metabolism. 2010; 11(6): 625-730.
Ghasemi A, Zahediasl S, Syedmoradi L, Azizi F. Low serum magnesium levels in elderly subjects with
metabolic syndrome. Biol Trace Elem Res. 2010; 136(1): 18–25. doi: 10.1007/s12011-009-8522-7. PMID:
Esmaillzadeh A, Azadbakht L. Dietary energy density and the metabolic syndrome among Iranian women.
Eur J Clin Nutr. 2011; 65(5): 598–605. doi: 10.1038/ejcn.2010.284. PMID: 21224871.
Esteghamati A, Noshad S, Khalilzadeh O, Morteza A, Nazeri A, Meysamie A, et al. Contribution of serum
leptin to metabolic syndrome in obese and nonobese subjects. Arch Med Res. 2011; 42(3): 244–51. doi:
1016/j.arcmed.2011.05.005. PMID: 21722822.
Mehrkesh M, Mohammadian S, Ghorbani M, Eshghinia S, Shafa N. Prevalency of metabolic syndrome
among adolescents aged 15 to 17 years in Gorgan, Northern Iran (2009). Journal of Gorgan University of
Medical Sciences. 2011; 13(Suppl 2): 93-9.
Noshad N, Abbasi M, Etemad A, Afarideh M, Khajeh E, Asgari F, et al. The Prevalence of Metabolic
Syndrome in Iran: a 2011 Update. J Diabetes. 2016: 34(5): 1243-8. doi: 10.1111/1753-0407.12438. PMID:
Ebrahimi Mamghani M, Farsad Naeimi AR, Noor Mohamadi M, Ozbodftari N. Prevalence of metabolic
syndrome in firefighters Tabriz. Bhbood. 2011; 15(4): 296-302.
Rahmanian K, Shojaie M. Prevalence of Metabolic Syndrome in an Adult Urban Population in The South
of Iran. Iranian Journal of Diabetes and Obesity. 2011; 3(2): 77-82.
Ramezani Tehrani F, Tohidi M, Rostami M, Asgari S, Azizi F. The association between sub-clinical
hypothyroidism and metabolic syndrome: A population based study. Iran J Endocrinol Metab. 2011; 13(1):
–105.
Hadaegh F, Zabetian A, Khalili D, Safarkhani M, James WPT, Azizi F. A new approach to compare the
predictive power of metabolic syndrome defined by a joint interim statement versus its components for
incident cardiovascular disease in Middle East Caucasian residents in Tehran. J Epidemiol Community
Health. 2012; 66(5): 427–32. doi: 10.1136/jech.2010.117697. PMID: 21051780.
Ghorbani R, Naeini BA, Eskandarian R, Rashidy-Pour A, Khamseh ME, Malek M. Prevalence of
metabolic syndrome according to ATPIII and IDF criteria in the Iranian population. Koomesh. 2012; 14(1):
–75.
Marjani M, Moghasemi S. The Metabolic Syndrome among Postmenopausal Women in Gorgan. Int J
Endocrinol. 2012; 2012: 953627. doi: 10.1155/2012/953627. PMID: 22518135, PMCID: PMC3296160.
Mahjoub S, Haji Ahmadi M, Faramarzi M, Ghorbani H, Moazezi Z. The prevalence of metabolic syndrome
according to the Iranian Committee of Obesity and ATP III criteria in Babol, North of Iran. Caspian J
Intern Med. 2012; 3(2): 410-6. PMID: 24358435, PMCID: PMC3861904.
Yousefzadeh G, Shokoohi M, Yeganeh M, Najafipour H. Role of gamma-glutamyl transferase (GGT) in
diagnosis of impaired glucose tolerance and metabolic syndrome: a prospective cohort research from the
Kerman Coronary Artery Disease Risk Study (KERCADRS). Diabetes Metab Syndr. 2012; 6(4): 190–4.
doi: 10.1016/j.dsx.2012.08.013. PMID: 23199536.
Mohebbi I, Saadat S, Aghassi M, Shekari M, Matinkhah M, et al. Prevalence of Metabolic Syndrome in
Iranian Professional Drivers: Results from a Population Based Study of 12,138 Men. PLoS One. 2012;
(2): e31790. doi:10.1371/journal.pone.0031790. PMID: 22384075.
Yazdi Z, Sarreshtedari M, Taiefi MH. Prevalence of metabolic syndrome and its associated factors among
drivers of heavy vehicles. Journal of Birjand University of Medical Sciences. 2012; 5(4): 68-72.
Rezaianzadeh A, Namayandeh SM, Sadr SM. National cholesterol education program adult treatment panel
III versus international diabetic federation definition of metabolic syndrome, which one is associated with
diabetes mellitus and coronary artery disease? Int J Prev Med. 2012; 3: 552-8. PMID: 22973485, PMCID:
PMC3429802.
Zarkesh M, Faam B, Daneshpour MS, Azizi F, Hedayati M. The relationship between metabolic syndrome,
cardiometabolic risk factors and inflammatory markers in a tehranian population: The tehran lipid and
glucose study. Inte Med. 2012; 51(24): 3329–35. doi: 10.2169/internalmedicine.51.8475.
Talaei M, Thomas GN, Marshall T, Sadeghi M, Iranipour R, Oveisgharan S, et al. Appropriate cut-off
values of waist circumference to predict cardiovascular outcomes: 7-year follow-up in an iranian
population. Int Med. 2012; 51(2): 139–46. doi: 10.2169/internalmedicine.51.6132. 56) Azimi-Nezhad M, Herbeth B, Siest G, Dade S, Ndiaye NC, Esmaily H, et al. High prevalence of metabolic
syndrome in Iran in comparison with France: what are the components that explain this? Metab Syndr Relat
Disord. 2012; 10(3): 181–8. doi: 10.1089/met.2011.0097. PMID: 22283632.
Movahed A, Larijani B, Nabipour I, Kalantarhormozi M, Asadipooya K, Vahdat K, et al. Reduced serum
osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome
components in postmenopausal women: the crosstalk between bone and energy metabolism. J Bone Miner
Metab. 2012; 30(6): 683–91. doi: 10.1007/s00774-012-0367-z. PMID: 22752126.
Shahbazian H, Latifi SM, Jalali MT, Shahbazian H, Amani R, Nikhoo A, et al. Metabolic syndrome and its
correlated factors in an urban population in South West of Iran. Journal of Diabetes & Metabolic Disorders.
; 12: 11. doi: 10.1186/2251-6581-12-11. PMID: 23497506.
Gholipour M, Tabrizi A, Kazem Neshad A. Prevalence of metabolic syndrome in students and its
relationship with obesity markers. Iran Diabetes and Lipid Journal. 2013; 12(4): 324-34.
Ahmadi A, Gharipour M, Nouri F, Sarrafzadegan N. Metabolic Syndrome in Iranian Youths: A Population- Based Study on Junior and High Schools in Rural and Urban Areas. J Diabetes Res. 2013; 2013: 738485.
doi: 10.1155/2013/738485. PMID: 23819128.
Shahini N, Shahin I, Marjani A. The Metabolic Syndrome among Turkmen Ethnic Groups in Gorgan, Iran.
Journal of Clinical and Diagnostic Research. 2013; 7(9): 1849-51. doi: 10.7860/JCDR/2013/6035.3331.
PMID: 24179879.
Maharlouei N, Bellissimo N, Ahmadi SM, Lankarani KB. Prevalence of metabolic syndrome in pre- and
postmenopausal Iranian women. Climacteric. 2013; 16: 561–7. doi: 10.3109/13697137.2012.727504.
PMID: 23157491.
Faam B, Hosseinpanah F, Amouzegar A, Ghanbarian A, Asghari G, Azizi F. Leisure-time physical activity
and its association with metabolic risk factors in Iranian adults: Tehran Lipid and Glucose Study, 2005- 2008. Prev Chronic Dis. 2013; 10: 36. doi: 10.5888/ pcd10.120194. PMID: 23489641.
Ziaee A, Esmailzadehha N, Ghorbani A, Asefzadeh S. Association between Uric Acid and Metabolic
Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran. Glob J Health Sci. 2013; 5(1): 155–65. doi:
5539/gjhs.v5n1p155. PMID: 23283048.
Ostovaneh MR, Zamani F, Sharafkhah M, Ansari-Moghaddam A, Akhavan Khaleghi N, Saeedian FS, et al.
Prevalence of metabolic syndrome in Amol and Zahedan, Iran: A population based study. Arch Iran Med.
; 17(7): 477–82. doi: 0141707/AIM.006. PMID: 24979559.
Javadi HR, Hashemipour S, Abbasi M, Javadi A. Prevalence of metabolic syndrome and its components in
over 24 years old population of Qazvin (2012). JQUMS. 2014; 18(3): 11-7.
Rashidi H, Payami SP, Latifi SM, Karandish M, Moravej Aleali A, Aminzadeh M, et al. Prevalence of
metabolic syndrome and its correlated factors among children and adolescents of Ahvaz aged 10–19.
Journal of Diabetes & Metabolic Disorders. 2014; 13: 53. doi: 10.1186/2251-6581-13-53. PMID:
Amiri P, Deihim T, Hosseinpanah F, Barzin M, Hasheminia M, Montazeri A, et al. Research: Educational
and Psychological Issues Diagnostic values of different definitions of metabolic syndrome to detect poor
health status in Iranian adults without diabetes. Diabet Med. 2014; 31: 854–61. doi: 10.1111/dme.12443.
Gozashti MH, Fedaei N, Shojaei M, Najafipour H. Determination of most suitable cut off point of waist
circumference for diagnosis of metabolic syndrome in Kerman. Diabetes Metab Syndr. 2014; 8: 8–12. doi:
1016/j.dsx.2013.10.022. PMID: 24661751.
Hosseinpanah F, Salehpour M, Asghari G, Barzin M, Mirmiran P, Hatami H, et al. Adolescent metabolic
phenotypes and early adult metabolic syndrome: Tehran lipid and glucose study. Diabetes Research and
Clinical Practice. 2015; 109: 287-92. doi: 10.1016/j.diabres.2015.05.022. PMID: 26026779.
Tabatabaie AH, Shafiekhani M, Nasihatkon AA, Hafizi Rastani I, Tabatabaie M, Borzoo AR, et al.
Prevalence of metabolic syndrome in adult population in Shiraz, southern Iran. Diabetes Metab Syndr.
; 9: 153–6. doi: 10.1016/j.dsx.2015.04.012. PMID: 25952039.
Alavi SS, Makarem J, Mehrdad R, Abbasi M. Metabolic syndrome: A common problem among office
workers. Int J Occup Environ Med. 2015; 6: 34-40. doi: 10.15171/ijoem.2015.492. PMID: 25588224.
Azak S, Mohebbi M, Salarilak Sh, Gharaaghaji Asl R. Prevalence of metabolic syndrome and related risk
factors in professional drivers in West Azerbaijan, 2010- 2012. The Journal of Urmia University of Medical
Sciences. 2015; 26(9): 775-84.
Moradi M, Rafiei E, Ebrahim Zadeh F, Baba H, Balaro S, Ali Mohammadi M. The prevalence of metabolic
syndrome among students of Lorestan University of Medical Sciences. Medical Journal of Mashhad,
University of Medical Sciences. 2015; 57(8): 918- 25.
Zardast M, Namakin K, Chahkandi T, Taheri F, Kazemi T, Bijari B. Prevalence of metabolic syndrome in
elementary school children in East of Iran. J Cardiovasc Thorac Res. 2015; 7(4): 158-63. doi:
15171/jcvtr.2015.34. PMID: 26702345.
Mohammadi Sh, Mirmiran P, Bahadoran Z, Mehrabi Y, Azizi F. The Association of Dairy Intake with
Metabolic Syndrome and Its Components in Adolescents: Tehran Lipid and Glucose Study. Int J
Endocrinol Metab. 2015; 13(3): e25201. doi: 10.5812/ijem.25201v2. PMID: 26425126.
Namazi Shabestari A, Asadi M, Jouyandeh Z, Qorbani M, Kelishadi R. Association of Lipid Accumulation
Product with Cardio-Metabolic Risk Factors in Postmenopausal Women. Acta Med Iran. 2016; 54(6): 370- 5. PMID: 27306343.
Yousefzadeh Gh, Shokoohi M, Najafipour H, Shadkamfarokhi M. Applying the Framingham risk score for
prediction of metabolic syndrome: The Kerman Coronary Artery Disease Risk Study, Iran. ARYA
Atheroscler. 2015; 11(3): 179-85. PMID: 26405450
Mousavi A, biglariA, Reyhanian M. Prevalence of Metabolic Syndrome and Its Related Criteria in Health
Network Personnel in Babolsar, 2012. J Mazandaran Univ Med Sci. 2015; 25(122): 379-83.
Ebrahimi H, Emamian MH, Shariati M, Hashemi H, Fotouhi A. Metabolic syndrome and its risk factors
among middle aged population of Iran, a population based study. Diabetes Metab Syndr. 2016; 10: 19–22.
doi: 10.1016/j.dsx.2015.08.009. PMID: 26341930
Ebrahimi MH, Delvarianzadeh M, Saadat S. Prevalence of metabolic syndrome among Iranian
occupational drivers. Diabetes Metab Syndr. 2016; 10: 46–51. doi: 10.1016/j.dsx.2015.09.011.
Baygi FC, Jensen O, Qorbani M, Farshad A, Salehi SA, Mohammadi-Nasrabadi F, et al. Prevalence and
associated factors of cardio-metabolic risk factors in Iranian seafarers. Int Marit Health. 2016; 67(2): 59–
doi: 10.5603/IMH.2016.0013. PMID: 27364169.
Ahrens W, Moreno LA, Mårild S, Molnár D, Siani A, De Henauw S, et al. Metabolic syndrome in young
children: definitions and results of the IDEFICS study. Int J Obes. 2014; 38(Suppl 2): S4-14. doi:
1038/ijo.2014.130 I. PMID: 25376220.
De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes
mellitus. Diab Vasc Dis Res. 2007; 4(4): 285–96. doi: 10.3132/dvdr.2007.055. PMID: 18158698.
Rosini N, Moura SA, Rosini RD, Machado MJ, Silva EL. Metabolic Syndrome and Importance of
Associated Variables in Children and Adolescents in Guabiruba - SC, Brazil. Arq Bras Cardiol. 2015;
(1): 37-44. doi: 10.5935/abc.20150040. PMID: 25993484.
Rodriguez Moran M, Salazar-Vazquez B, Violante R, Guerrero-Romero F. Metabolic syndrome among
children and adolescents aged 10-18-years. Diabetes Care. 2004; 27(10): 2516–7. doi:
2337/diacare.27.10.2516. PMID: 15451932.
Inanc BB. Metabolic Syndrome in School Children in Mardin, South-Eastern of Turkey. Eurasian J Med
; 46(3): 156-63. doi: 10.5152/eajm.2014.39. PMID: 25610318.
Harabbi I, Bouaouina M, Maatoug J, Gaha R, Ghannem H. Prevalence of the metabolic syndrome among
urban schoolchildren in Sousse, Tunisia. Int J Cardiol. 2009; 135(1): 130–1. doi:
1016/j.ijcard.2008.01.035. PMID: 18495275.
Liu W, Lin R, Liu A, Du L, Chen Q. Prevalence and association between obesity and metabolic syndrome
among Chinese elementary school children: a school-based survey. BMC Public Health. 2010; 10: 780.
doi: 10.1186/1471-2458-10-780. PMID: 21176200.
Singh R, Bhansali A, Sialy R, Aggarwal A. Prevalence of metabolic syndrome in adolescents from a north
Indian population. Diabet Med. 2007; 24(2): 195–9. doi:10.1111/j.1464-5491.2007.02066.x. PMID:
Iqbal AZ, Basharat S, Basharat A, Basharat S. Prevalence of the metabolic syndrome and its component
abnormalities among school age Pakistani children. J Ayub Med Coll Abbottabad. 2014; 26(2): 194-9.
PMID: 25603676.
Zardast M, Namakin K, Chahkandi T, Taheri F, Kazemi T, Bijari B. Prevalence of Metabolic Syndrome in
Elementary School Children in East of Iran. J Cardiovasc Thorac Res. 2015; 7(4): 158-63. doi:
15171/jcvtr.2015.34. PMID: 26702345.
Conceicao-Machado ME, Silva LR, Santana ML, Pinto EJ, Silva Rde C, Moraes LT, et al.
Hypertriglyceridemic waist phenotype: association with metabolic abnormalities in adolescents. J Pediatr.
; 89: 56–63. doi: 10.1016/j.jped.2013.02.009. PMID: 23544811.
International diabetes federation Icwadotms. Available from:
http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf.
Boonyavarakul A, Choosaeng C, Supasyndh O, Panichkul S. Prevalence of the metabolic syndrome, and its
association factors between percentage body fat and body mass index in rural Thai population aged 35
years and older. J Med Assoc Thai. 2005; 88(Suppl 3): 121–30. PMID: 16858950.
Corbaton-Anchuelo A, Martinez-Larrad MT, Fernandez-Perez C, Vega-Quiroga S, Ibarra-Rueda JM,
Serrano-Rios M, et al. Metabolic syndrome, adiponectin, and cardiovascular risk in Spain (the Segovia
study): impact of consensus societies criteria. Metab Syndr Relat Disord. 2013; 11(5): 309–18. doi:
1089/met.2012.0115. PMID: 23734759.
Giampaoli S, Stamler J, Donfrancesco C, Panico S, Vanuzzo D, Cesana G, et al. The metabolic syndrome:
a critical appraisal based on the CUORE epidemiologic study. Prev Med. 2009; 48(6): 525–31. doi:
1016/j.ypmed.2009.03.017. PMID: 19344739.
Fonseca MJ, Gaio R, Lopes C, Santos AC. Association between dietary patterns and metabolic syndrome in
a sample of Portuguese adults. Nutr J. 2012; 11: 64. doi: 10.1186/1475-2891-11-64. PMID: 22943133.
Wagner A, Dallongeville J, Haas B, Ruidavets JB, Amouyel P, Ferrieres J, et al. Sedentary behaviour,
physical activity and dietary patterns are independently associated with the metabolic syndrome. Diabetes
Metab. 2012; 38(5): 428–35. doi: 10.1016/j.diabet.2012.04.005. PMID: 22721723.
Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic
syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013; 62(8): 697–703. doi:
1016/j.jacc.2013.05.064. PMID: 23810877.
Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008; 28(4): 629–36.
doi: 10.1161/ATVBAHA.107.151092. PMID: 18174459.
Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of metabolic syndrome and its
relationship to white blood cell count in a population of Thai men and women receiving routine health
examinations. Am J Hypertens. 2006; 19: 339–45. doi: 10.1016/j.amjhyper.2005.10.008. PMID: 16580566.
Wang GR, Li L, Pan YH, Tian GD, Lin WL, Li Z, et al. Prevalence of metabolic syndrome among
urban community residents in China. BMC Public Health. 2013; 13: 599. doi: 10.1186/1471-2458-13-599.
PMID: 23786855.
Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of metabolic syndrome and its association with
cardiovascular disease in korea. J Korean Med Sci. 2004; 19: 195-201. doi: 10.3346/jkms.2004.19.2.195.
PMID: 15082890.
Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, Majdzadeh R, et al. Paediatric
metabolic syndrome and associated anthropometric indices: the CASPIAN Study. Acta Paediatr. 2006;
(12): 1625–34. doi: 10.1080/08035250600750072. PMID: 17129973.
Belfki H, Ben Ali S, Aounallah-Skhiri H, Traissac P, Bougatef S, Maire B, et al. Prevalence and
determinants of the metabolic syndrome among Tunisian adults: results of the Transition and Health Impact
in North Africa (TAHINA) project. Public Health Nutr. 2013; 16(4): 582–90. doi:
1017/S1368980012003291. PMID: 22883486.
Pinzon JB, Serrano NC, Diaz LA, Mantilla G, Velasco HM, Martinez LX, et al. Impact of the new
definitions in the prevalence of the metabolic syndrome in an adult population at Bucaramanga, Colombia.
Biomedica. 2007; 27(2): 172–9. doi: /S0120-41572007000800004. PMID: 17713628.
Florez H, Silva E, Fernandez V, Ryder E, Sulbaran T, Campos G, et al. Prevalence and risk factors
associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed
Hispanics in Zulia State, Venezuela. Diabetes Res Clin Pract. 2005; 69(1): 63–77. doi:
1016/j.diabres.2004.11.018. PMID: 15955388.
Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults.
JAMA. 2002; 287(Suppl 3): 356-9. PMID: 11790215.
Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic
syndrome: prevalence and associated risk factor findings in the US population from the Third National
Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003; 163(4): 427–36. doi:
1001/archinte.163.4.427. PMID: 12588201, PMCID: PMC3146257.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
